Immunogenic composition comprising a bovine viral diarrhea virus type 1B modified Live vaccine and a Carrier acceptable Veterinary； he understands； and its use to Prevent, Treat, manage or reduce one or more symptoms of a disease caused by pestivirus.
Disclosed are immunogenic compositions, and methods for their use in the formulation and administration of therapeutic and prophylactic pharmaceutical agents. In particular, the invention provides immunogenic compositions and methods for preventing, treating, managing, and/or ameliorating a viral or microbial infection, or one or more symptoms thereof, including, for example, those infections giving rise to shipping fever, bovine respiratory disease complex, and/or bovine viral diarrhea, particularly in susceptible or infected animals.COMPOSICION INMUNOGENICA QUE COMPRENDE UN VIRUS DE DIARREA VIRAL BOVINA TIPO 1b VIVO MODIFICADO Y UN PORTADOR VETERINARIO ACEPTABLE； VACUNA QUE LA COMPRENDE； Y SU USO PARA PREVENIR, TRATAR, MANEJAR O ALIVIAR UNO O MAS SINTOMAS DE UNA ENFERMEDAD CAUSADA POR PESTIVIRUS.
